Skip to main content
Clinical Trials/NCT02355691
NCT02355691
Terminated
Not Applicable

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

University of North Carolina, Chapel Hill1 site in 1 country16 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complications; Arthroplasty, Infection or Inflammation
Sponsor
University of North Carolina, Chapel Hill
Enrollment
16
Locations
1
Primary Endpoint
Mean Wound Healing Scores by the ASEPSIS Criteria
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

For the target population of adult patients following primary total hip arthroplasty, the randomized clinical trial will be used to evaluate the efficacy of the use of a mobile negative pressure wound therapy(NPWT) device compared to a standard absorptive dressing in the immediate postoperative period. We will apply two dressing types and evaluate the postoperative wounds with a wound scoring system (ASEPSIS) that incorporates multiple variables of wound infection risk.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
May 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing primary total hip arthroplasty.

Exclusion Criteria

  • age less than 18 y/o
  • Total hip arthroplasty for fracture
  • Revision or conversion total hip arthroplasty
  • inability to personally consent to participation due to cognitive impairment, intoxication or sedation
  • multiple surgical procedures
  • Patients taking immune modulating medication(prednisone, methotrexate, anakinra, etc.)
  • skin hypersensitivity to acrylic adhesive or silver.
  • Inability to care for dressing due to physical or mental incapacitation

Outcomes

Primary Outcomes

Mean Wound Healing Scores by the ASEPSIS Criteria

Time Frame: (Single point evaluation)-2 weeks post surgery visit

A method of evaluating wounds for infection risk that incorporates multiple wound healing factors such as erythema, drainage, and dehiscence is the ASEPSIS (Additional treatment, presence of Serous discharge, Erythema, Purulent exudate, Separation of the deep tissue, Isolation of bacteria, and duration of inpatient Stay) wound scoring system. Originally developed and validated for cardiac surgery sternal wounds, ASEPSIS evaluates the wound for the severity of multiple factors linked with surgical site infection. This includes dehiscence, exudate/discharge, and erythema. The higher the score, the more likely a surgical site infection will be present. This score will give us a more diverse picture of postoperative wound healing and the influence of Negative Pressure Wound Therapy. Scores can range from 0 to 65, with most scores expected at the lower scale.

Secondary Outcomes

  • Number of Participants With Infection((Single point evaluation)-6 weeks post surgery visit)

Study Sites (1)

Loading locations...

Similar Trials